Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

T Cell Versus T Cell; A Study of the Immune Checkpoint Landscape in Cutaneous T Cell Lymphoma

Duncan Murray, FRCPath, MRCP, MA, BMBS, Suzy A Eldershaw, BSc. (Hons.), PhD, Hayden Pearce, BSc. (Hons.), PhD, Nathaniel Davies, MSci, PhD, Jack McMurray, BSc, Julia J. Scarisbrick, MD FRCP, MBBS †, Paul Moss, MBBS, PhD FRCP

Blood (2017) 130 (Supplement 1): 2754.

https://doi.org/10.1182/blood.V130.Suppl_1.2754.2754

Published: 2017

Journal Articles

Updated Analyses of the International, Open-Label, Randomized, Phase 3 Alcanza Study: Longer-Term Evidence for Superiority of Brentuximab Vedotin Versus Methotrexate or Bexarotene for CD30-Positive Cutaneous T-Cell Lymphoma (CTCL)

Blood (2017) 130 (Supplement 1): 1509.

https://doi.org/10.1182/blood.V130.Suppl_1.1509.1509

Published: 2017

Journal Articles

Brentuximab Vedotin Demonstrates Significantly Superior Clinical Outcomes in Patients with CD30-Expressing Cutaneous T Cell Lymphoma Versus Physician's Choice (Methotrexate or Bexarotene): The Phase 3 Alcanza Study

Youn H Kim, MD, Sean Whittaker, MB, ChB, FRCP, MD, Steven M Horwitz, MD, Madeleine Duvic, MD, Reinhard Dummer, MD, Julia J Scarisbrick, MBChB FRCP MD, Pietro Quaglino, MD, Pier Luigi Zinzani, MD PhD, Pascal Wolter, MD, Yinghui Wang, MS, Maria Corinna Palanca-Wessels, MD PhD, Erin Zagadailov, PharmD, MS, William L Trepicchio, PhD, Yi Liu, PhD, Meredith Little, MPH, H Miles Prince, MD

Blood (2016) 128 (22): 182.

https://doi.org/10.1182/blood.V128.22.182.182

Published: 2016

Journal Articles

A Cutaneous Lymphoma International Consortium ‘CLIC’ study of Prognostic Parameters in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Progress Towards Establishing a Prognostic Index to Augment Clinical Staging

Julia J Scarisbrick, MBhons ChB FRCP MD, Pietro Quaglino, Maarten Vermeer, Sean Whittaker, Gary S. Wood, MD, Madeleine Duvic, MD, Miles Prince, MD FRACP, FRCPA, Steven M. Horwitz, MD, Richard T. Hoppe, MD, Pierluigi Porcu, MD, Rudolf Stadler, MD, Felicity Evison, Youn H Kim, MD

Blood (2014) 124 (21): 1621.

https://doi.org/10.1182/blood.V124.21.1621.1621

Published: 2014

Journal Articles

A Multicentre Retrospective UK Study Detailing Onset Of Graft Verus Host Disease, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem Cell Transpantation: Rates Of GVHD Are High But Death From GVHD Infrequent

Julia J Scarisbrick, MBhons ChB FRCP MD, Fiona L Dignan, Sameer Tulpule, Emma Das gupta, Gulnaz Shah, Antonio Pagliuca, Ram Malladi, Kavita Raj, MD, PhD, MRCP, FRCPath

Blood (2013) 122 (21): 4645.

https://doi.org/10.1182/blood.V122.21.4645.4645

Published: 2013

Journal Articles

Positive Effect of Extracorporeal Photopheresis In Reducing Immunosuppression in Patients with Chronic Graft Versus Host Disease.

Fiona L Dignan, BSc, MRCP, FRCPath, Danielle Greenblatt, MRCP, Michael Cox, Bronwen E. Shaw, PhD, MRCP, FRCPath, Julia J Scarisbrick, MD, MRCP

Blood (2010) 116 (21): 3452.

https://doi.org/10.1182/blood.V116.21.3452.3452

Published: 2010

Journal Articles

Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictors of response

Alun V. Evans, Blair P. Wood, Julia J. Scarisbrick, Elizabeth A. Fraser-Andrews, Sue Chinn, Alan Dean, Philip Watkins, Sean J. Whittaker, Robin Russell-Jones

Blood (2001) 98 (5): 1298–1301.

https://doi.org/10.1182/blood.V98.5.1298

Published: 2001

Journal Articles

Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma

Julia J. Scarisbrick, Sean Whittaker, Alun V. Evans, Elisabeth A. Fraser-Andrews, Fiona J. Child, Alan Dean, Robin Russell-Jones

Blood (2001) 97 (3): 624–630.

https://doi.org/10.1182/blood.V97.3.624

Published: 2001

Journal Articles

Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN

Julia J. Scarisbrick, Alison J. Woolford, Robin Russell-Jones, Sean J. Whittaker

Blood (2000) 95 (9): 2937–2942.

https://doi.org/10.1182/blood.V95.9.2937.009k15_2937_2942

Published: 2000

NARROW

T Cell Versus T Cell; A Study of the Immune Checkpoint Landscape in Cutaneous T Cell Lymphoma

Updated Analyses of the International, Open-Label, Randomized, Phase 3 Alcanza Study: Longer-Term Evidence for Superiority of Brentuximab Vedotin Versus Methotrexate or Bexarotene for CD30-Positive Cutaneous T-Cell Lymphoma (CTCL)

Brentuximab Vedotin Demonstrates Significantly Superior Clinical Outcomes in Patients with CD30-Expressing Cutaneous T Cell Lymphoma Versus Physician's Choice (Methotrexate or Bexarotene): The Phase 3 Alcanza Study

A Cutaneous Lymphoma International Consortium ‘CLIC’ study of Prognostic Parameters in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Progress Towards Establishing a Prognostic Index to Augment Clinical Staging

A Multicentre Retrospective UK Study Detailing Onset Of Graft Verus Host Disease, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem Cell Transpantation: Rates Of GVHD Are High But Death From GVHD Infrequent

Positive Effect of Extracorporeal Photopheresis In Reducing Immunosuppression in Patients with Chronic Graft Versus Host Disease.

Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictors of response

Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma

Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only